Raymond James & Associates’s Abiomed Inc ABMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-884
Closed -$217K 4121
2022
Q3
$217K Sell
884
-2,067
-70% -$558K ﹤0.01% 3399
2022
Q2
$730K Buy
2,951
+1,328
+82% +$358K ﹤0.01% 2660
2022
Q1
$538K Sell
1,623
-997
-38% -$307K ﹤0.01% 3031
2021
Q4
$941K Sell
2,620
-844
-24% -$285K ﹤0.01% 2654
2021
Q3
$1.13M Sell
3,464
-122
-3% -$41.3K ﹤0.01% 2495
2021
Q2
$1.12M Sell
3,586
-4,704
-57% -$1.44M ﹤0.01% 2513
2021
Q1
$2.64M Buy
8,290
+1,314
+19% +$421K ﹤0.01% 1827
2020
Q4
$2.26M Sell
6,976
-272
-4% -$75.2K ﹤0.01% 1816
2020
Q3
$2.01M Buy
7,248
+1,534
+27% +$442K ﹤0.01% 1767
2020
Q2
$1.38M Buy
5,714
+773
+16% +$155K ﹤0.01% 1947
2020
Q1
$717K Sell
4,941
-4,274
-46% -$710K ﹤0.01% 2189
2019
Q4
$1.57M Sell
9,215
-26,179
-74% -$4.85M ﹤0.01% 1982
2019
Q3
$6.3M Sell
35,394
-2,317
-6% -$501K 0.01% 1100
2019
Q2
$9.82M Sell
37,711
-2,395
-6% -$635K 0.01% 866
2019
Q1
$11.5M Buy
40,106
+8,368
+26% +$2.78M 0.02% 746
2018
Q4
$10.3M Sell
31,738
-10,242
-24% -$3.56M 0.02% 740
2018
Q3
$18.9M Buy
41,980
+16,606
+65% +$6.55M 0.03% 554
2018
Q2
$10.4M Sell
25,374
-4,146
-14% -$1.5M 0.02% 798
2018
Q1
$8.59M Buy
29,520
+9,913
+51% +$2.51M 0.02% 860
2017
Q4
$3.67M Buy
19,607
+1,180
+6% +$220K 0.01% 1299
2017
Q3
$3.11M Buy
18,427
+5,656
+44% +$855K 0.01% 1339
2017
Q2
$1.83M Buy
12,771
+4,001
+46% +$538K ﹤0.01% 1623
2017
Q1
$1.1M Buy
8,770
+293
+3% +$34K ﹤0.01% 1919
2016
Q4
$955K Sell
8,477
-8,186
-49% -$948K ﹤0.01% 1946
2016
Q3
$2.14M Buy
16,663
+5,795
+53% +$694K 0.01% 1409
2016
Q2
$1.19M Sell
10,868
-182
-2% -$18.1K ﹤0.01% 1640
2016
Q1
$1.05M Buy
+11,050
New +$933K ﹤0.01% 1648
2015
Q1
Sell
-13,025
Closed -$496K 2421
2014
Q4
$496K Sell
13,025
-1,675
-11% -$52.8K ﹤0.01% 1948
2014
Q3
$365K Hold
14,700
﹤0.01% 1962
2014
Q2
$370K Buy
+14,700
New +$342K ﹤0.01% 1974
2013
Q3
Sell
-11,738
Closed -$253K 2003
2013
Q2
$253K Buy
+11,738
New +$236K ﹤0.01% 1769

Other funds holding ABMD